{"id":1798,"date":"2023-06-10T12:39:35","date_gmt":"2023-06-10T10:39:35","guid":{"rendered":"https:\/\/priscus.eu\/home\/"},"modified":"2026-04-29T12:43:50","modified_gmt":"2026-04-29T10:43:50","slug":"home","status":"publish","type":"page","link":"https:\/\/www.priscus.eu\/en\/","title":{"rendered":"Home"},"content":{"rendered":"\n\n\t
\n\t\t\t\t\t\t<\/div>\n\t\t\t\t\t\t\t\t\t\t\tPriscus Finance, which has been active since 2004 with its team of around thirty professionals, combines cutting-edge and recognised expertise in corporate finance, strong multi-sector skills and an intimate knowledge of selected geographical areas.<\/p>\n\t\t\t\t\t\t\n\t\t\t\t\t\t\t\t\t\t\t\t\t
\n Transactions completed \n Professionals \n Offices worldwide (Paris, Milan, Sofia, Lisbon, Madrid, Bangalore, Montevideo, Singapore, Athens)<\/span>\n <\/p>\n <\/div>\n <\/div>\n \n Countries\/regions covered Priscus Finance accompagne Emeis (France) dans le cadre de la cession des r\u00e9sidences de Novara (Italie)<\/p>\n Priscus Italia assists Ara 1857 (Italy) in its due diligence process as part of its sale to Groupama Assicurazioni (Italy)<\/p>\n Priscus Italia advises ONHC on its sale process to Oakley Capital (UK)<\/p>\n Priscus advised Markel (USA) for the acquisition of All Risks (Italy)<\/p>\n
since 2014 <\/span>\n <\/p>\n <\/div>\n <\/div>\n
\r\nIncluding 14 partners <\/span>\n <\/p>\n <\/div>\n <\/div>\n
\r\nby partners and senior advisors <\/span>\n <\/p>\n <\/div>\n <\/div>\n <\/div>\n <\/div>\n Our activities<\/h2>\n
The Priscus team leverages its expertise and dynamism to help its clients achieve their objectives.<\/h4>\n
\n
Our preferred sectors<\/h2>\n
Bringing together a variety of complementary human skills, Priscus offers a wide range of sectoral expertise.<\/h4>\n <\/div>\n
Insurance, insurance brokerage and insurtech<\/h3>\n <\/div>\n <\/a>\n <\/div>\n <\/div>\n
Banking, financial intermediaries and fintech<\/h3>\n <\/div>\n <\/a>\n <\/div>\n <\/div>\n
Healthcare<\/h3>\n <\/div>\n <\/a>\n <\/div>\n <\/div>\n
Biotech and medtech via the dedicated structure,<\/h3>\n
Insurance, insurance brokerage and insurtech <\/h3>\n <\/div>\n <\/a>\n <\/div>\n <\/div>\n
Banking, financial intermediaries and fintech <\/h3>\n <\/div>\n <\/a>\n <\/div>\n <\/div>\n
Healthcare <\/h3>\n <\/div>\n <\/a>\n <\/div>\n <\/div>\n
Biotech and medtech via the dedicated structure, <\/h3>\n
Our latest transactions<\/h2>\n <\/div>\n
<\/span>\n <\/div>\n
<\/span>\n <\/div>\n
<\/span>\n <\/div>\n
<\/span>\n
<\/span>\n <\/div>\n
<\/span>\n <\/div>\n
<\/span>\n
<\/span>\n <\/div>\n
<\/span>\n <\/div>\n
<\/span>\n
<\/span>\n <\/div>\n